Cargando…
Pancreatic Ductal Adenocarcinoma: Characteristics of Tumor Microenvironment and Barriers to Treatment
Pancreatic ductal adenocarcinoma remains a highly aggressive disease, with a 5-year relative survival rate of 10%. Numerous barriers to treatment exist, such as dense desmoplasia, infiltration of immune suppressor cells, inhibitory cytokines, low effector T-cell infiltration, and low tumor mutationa...
Autores principales: | Kane, Sujata, Engelhart, Anne, Guadagno, Jessica, Jones, Aaron, Usoro, Innis, Brutcher, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646635/ https://www.ncbi.nlm.nih.gov/pubmed/33575066 http://dx.doi.org/10.6004/jadpro.2020.11.7.4 |
Ejemplares similares
-
The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma
por: Zhang, Jingchang, et al.
Publicado: (2022) -
Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
por: Smith, Caitlyn, et al.
Publicado: (2022) -
Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
por: Gola, Michał, et al.
Publicado: (2022) -
Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014) -
The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
por: Herremans, Kelly M., et al.
Publicado: (2022)